insights_auto
Mengapa EVGN naik 6,56%?
Pelajari Lebih Lanjutchevron_right
EVGN:NASDAQ
Evogene Ltd
US$0,43
arrow_upward
+6,56%(+0,026) 1 HR
6 Okt, 14.29.39 GMT-4 · USD
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk EVGN...
Pembukaan
US$0,39
Tinggi
US$0,44
Rendah
US$0,39
Kapitalisasi pasar
7,22 jt
Volume rata-rata
2,55 jt
Volume
227,69 rb
Harga tinggi dalam 52 minggu terakhir
US$1,50
Harga rendah dalam 52 minggu terakhir
US$0,35
EPS
-US$0,90
Beta
1,44
Saham beredar
15,80 jt
Jumlah karyawan
52
Pembukaan
US$0,39
Tinggi
US$0,44
Rendah
US$0,39
Kapitalisasi pasar
7,22 jt
Volume rata-rata
2,55 jt
Volume
227,69 rb
Harga tinggi dalam 52 minggu terakhir
US$1,50
Harga rendah dalam 52 minggu terakhir
US$0,35
EPS
-US$0,90
Beta
1,44
Saham beredar
15,80 jt
Jumlah karyawan
52
Artikel berita
Dari sumber web dan partner berita
AD HOC NEWS
·
1 hari yang lalu
Evogene stock fell 2.43 percent as Nasdaq deadline moved
Profil
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
Tentang Evogene Ltd